Electromed, Inc.
ELMDElectromed, Inc. in brief
Electromed, Inc. is a listed company in the Medical Equipment industry, based in New Prague, Minnesota, USA. Its market value was $341 M on 1 August 2026, which makes it the 14,245th largest listed company in the world and the 2,790th largest in the USA on this site. In the year to June 2026 it had sales of $74 M and a net profit of $11 M, about 15 cents of profit for every dollar of sales. It employs about 197 people and James L. Cunniff is its chief executive. Its shares trade under the symbol ELMD (NYSE).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells innovative products that provide airway clearance therapy, including the SmartVest® Airway Clearance System to patients with compromised pulmonary function with a commitment to excellence and compassionate service. Our goal is to make High Frequency Chest Wall Oscillation treatments as effective, convenient, and comfortable as possible, so our patients can breathe easier and live better with improved respiratory function and fewer exacerbations.
The SmartVest System generates HFCWO, an airway clearance therapy. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective therapy to clear the lung and airway from retained secretions and mucus which can harbor bacteria and lead to infection. One important factor of respiratory health is the ability to clear secretions from airways. Impaired airway clearance, when mucus cannot be expectorated, may result in labored breathing, inflammatory response and/or immune systems boosting mucus production that invites bacteria trapped in stagnant secretions to cause infections. Studies show that HFCWO therapy is as effective an airway clearance method for patients who have compromised pulmonary function as traditional chest physical therapy administered by a respiratory therapist.1 However, HFCWO can be self-administered, relieving a caregiver of participation in the therapy, and eliminating the attendant cost of an in-home care provider. We believe that HFCWO treatments are cost-effective primarily because they reduce a patient’s risk of respiratory infections and other secondary complications that are associated with impaired airway clearance and often result in costly hospital visits and repeated antibiotic use.
From the company's annual report filed with the US SEC: read the report
Electromed, Inc. timeline
- 2010
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2011
- 🔔· approximateInitial public offering on NYSE
- 2026
- 💰Record revenue of $74 millionFY2026, the highest of the 9 years on record.
- 💰Record net income of $11 millionFY2026, the highest profit of the 9 years on record.
Events of Electromed, Inc. from SEC EDGAR, the company record and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #3,897 (Jan 2020) · #3,791 (Jan 2021) · #4,330 (Jan 2022) · #4,417 (Dec 2022) · #4,312 (Jul 2023) · #3,752 (Jan 2024) · #1,713 (Mar 2026) · #2,774 (Aug 2026)
Key ratios
- P/E ratio (TTM)
- 28.6×
- Price / sales (TTM)
- 4.5×
- Price / book
- 6.3×
- Free cash flow yield
- 2.5%
- Net margin (TTM)
- 15.8%
- Operating margin
- 18.8%
- Return on equity
- 22.1%
- Liabilities / assets
- 18.5%
- Net debt
- $-4M
- Revenue growth
- +15.3%
- R&D / revenue
- 1.8%
- Revenue per employee
- $375 K
- Profit per employee
- $57 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $74M | +15.3% | $14M | $11M | 15.3% |
| Jun 2025 | $64M | +17.0% | $10M | $8M | 11.8% |
| Jun 2024 | $55M | +13.8% | $7M | $5M | 9.4% |
| Jun 2023 | $48M | +15.4% | $4M | $3M | 6.6% |
| Jun 2022 | $42M | +16.5% | $3M | $2M | 5.5% |
| Jun 2021 | $36M | +10.1% | $3M | $2M | 6.6% |
| Jun 2020 | $32M | +3.7% | $5M | $4M | 12.8% |
| Jun 2019 | $31M | — | $3M | $2M | 6.3% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Jun 2026 | $10M | $1M | $8M | $1.30 | — |
| Jun 2025 | $11M | $0M | $11M | $0.85 | — |
| Jun 2024 | $9M | $0M | $9M | $0.58 | — |
| Jun 2023 | $1M | $2M | $-0M | $0.36 | — |
| Jun 2022 | $-1M | $1M | $-2M | $0.26 | — |
| Jun 2021 | $3M | $0M | $3M | $0.27 | — |
| Jun 2020 | $4M | $1M | $3M | $0.47 | — |
| Jun 2019 | $3M | $1M | $1M | $0.23 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $19M (+10.6% on a year earlier), net income $3M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.
SEC filings
- Nov 10, 202610-QQuarterly report · period to Sep 2026
- Nov 10, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Sep 29, 2026DEF 14AProxy statement
- Aug 25, 20268-KCurrent reportResults of operations · Directors or officers changed · Regulation FD disclosure
- Aug 25, 202610-KAnnual report · period to Jun 2026
- May 12, 202610-QQuarterly report · period to Mar 2026
- May 12, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Feb 10, 202610-QQuarterly report · period to Dec 2025
- Feb 10, 20268-KCurrent reportResults of operations · Regulation FD disclosure
- Dec 18, 20258-KCurrent reportMaterial agreement · New financial obligation
- Nov 18, 20258-KCurrent reportShareholder vote
- Nov 12, 202510-QQuarterly report · period to Sep 2025
Official filings of Electromed, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $74 M
- Operating income
- $14 M
- Net income
- $11 M
For year ending June-2026 · source: SEC filing
Balance sheet
- Total assets
- $66 M
- Total liabilities
- $12 M
- Total equity
- $54 M
As of June-2026
Top 100 institutional investors in Electromed, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 476,970 | +11,351 (+2.44%) | 5.84% | $13 M | Nov 13, 2026 |
| 2 | J.E. Simmons & Co., P.C. | 468,322 | -15,500 (-3.20%) | 5.73% | $13 M | Nov 12, 2026 |
| 3 | Vanguard Capital Management LLC | 285,658 | +2,426 (+0.86%) | 3.49% | $8 M | Nov 13, 2026 |
| 4 | Geode Capital Management, LLC | 269,104 | +51,989 (+23.95%) | 3.29% | $8 M | Nov 6, 2026 |
| 5 | Punch & Associates Investment Management, Inc. | 196,332 | -22,188 (-10.15%) | 2.40% | $6 M | Nov 16, 2026 |
| 6 | Acadian Asset Management LLC | 183,489 | -38,356 (-17.29%) | 2.24% | $5 M | Nov 9, 2026 |
| 7 | Dimensional Fund Advisors LP | 181,399 | +952 (+0.53%) | 2.22% | $5 M | Nov 4, 2026 |
| 8 | Two Sigma Investments, LP | 158,157 | -9,335 (-5.57%) | 1.93% | $4 M | Nov 16, 2026 |
| 9 | Hunter Associates Investment Management LLC | 157,278 | +1,400 (+0.90%) | 1.92% | $4 M | Oct 26, 2026 |
| 10 | Arrowstreet Capital, Limited Partnership | 143,632 | +76,834 (+115.02%) | 1.76% | $4 M | Nov 13, 2026 |
| 11 | GAMCO Investors, Inc. Et Al | 142,000 | 0 (0.00%) | 1.74% | $4 M | Nov 12, 2026 |
| 12 | Renaissance Technologies LLC | 128,514 | +28,810 (+28.90%) | 1.57% | $4 M | Nov 12, 2026 |
| 13 | State Street Corp | 110,913 | -1,703 (-1.51%) | 1.36% | $3 M | Nov 12, 2026 |
| 14 | Vanguard Portfolio Management LLC | 104,124 | +19,827 (+23.52%) | 1.27% | $3 M | Nov 13, 2026 |
| 15 | Goldman Sachs Group Inc | 98,352 | +25,648 (+35.28%) | 1.20% | $3 M | Nov 16, 2026 |
| 16 | Lazard Asset Management LLC | 96,579 | +3,107 (+3.32%) | 1.18% | $3 M | Nov 16, 2026 |
| 17 | Northern Trust Corp | 85,075 | +937 (+1.11%) | 1.04% | $2 M | Nov 16, 2026 |
| 18 | Qube Research & Technologies Ltd | 79,210 | +44,864 (+130.62%) | 0.97% | $2 M | Nov 13, 2026 |
| 19 | White Pine Capital LLC | 69,937 | -63 (-0.09%) | 0.86% | $2 M | Nov 9, 2026 |
| 20 | Morgan Stanley | 66,548 | +21,368 (+47.30%) | 0.81% | $2 M | Nov 13, 2026 |
| 21 | Man Group plc | 64,017 | +26,168 (+69.14%) | 0.78% | $2 M | Nov 16, 2026 |
| 22 | Bridgeway Capital Management, LLC | 52,302 | -5,261 (-9.14%) | 0.64% | $1 M | Nov 16, 2026 |
| 23 | Vanguard Fiduciary Trust Co | 50,973 | +1,242 (+2.50%) | 0.62% | $1 M | Nov 13, 2026 |
| 24 | Bank of New York Mellon Corp | 47,933 | +1,911 (+4.15%) | 0.59% | $1 M | Nov 5, 2026 |
| 25 | Ameriprise Financial Inc | 46,123 | +3,780 (+8.93%) | 0.56% | $1 M | Nov 16, 2026 |
Show all 100: investors 26 to 100
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Y-Intercept (Hong Kong) Ltd | 42,854 | New | 0.52% | $1 M | Oct 16, 2026 |
| 27 | Raymond James Financial Inc | 41,883 | -2,812 (-6.29%) | 0.51% | $1 M | Nov 12, 2026 |
| 28 | Isthmus Partners, LLC | 41,544 | New | 0.51% | $1 M | Oct 21, 2026 |
| 29 | BNP Paribas Financial Markets | 39,740 | -3,275 (-7.61%) | 0.49% | $1 M | Nov 12, 2026 |
| 30 | Oak Ridge Investments LLC | 39,511 | +247 (+0.63%) | 0.48% | $1 M | Oct 30, 2026 |
| 31 | Globeflex Capital L P | 35,470 | 0 (0.00%) | 0.43% | $1 M | Nov 16, 2026 |
| 32 | North Star Investment Management Corp. | 34,000 | 0 (0.00%) | 0.42% | $1 M | Oct 27, 2026 |
| 33 | Bernicke Wealth Management, Ltd. | 32,622 | 0 (0.00%) | 0.40% | $1 M | Nov 6, 2026 |
| 34 | AQR Capital Management LLC | 32,438 | -4,703 (-12.66%) | 0.40% | $1 M | Nov 16, 2026 |
| 35 | Gabelli Funds LLC | 30,700 | 0 (0.00%) | 0.38% | $1 M | Nov 12, 2026 |
| 36 | NLB Skladi, upravljanje premozenja, d.o.o. | 30,263 | 0 (0.00%) | 0.37% | $1 M | Oct 22, 2026 |
| 37 | Jpmorgan Chase & Co | 28,274 | +2,611 (+10.17%) | 0.35% | $1 M | Nov 12, 2026 |
| 38 | Strs Ohio | 26,300 | +9,100 (+52.91%) | 0.32% | $1 M | Oct 30, 2026 |
| 39 | LPL Financial LLC | 22,128 | +704 (+3.29%) | 0.27% | $1 M | Nov 6, 2026 |
| 40 | Quadrature Capital Ltd | 21,211 | +9,920 (+87.86%) | 0.26% | $1 M | Nov 13, 2026 |
| 41 | Aristides Capital LLC | 20,383 | -15,639 (-43.42%) | 0.25% | $1 M | Nov 16, 2026 |
| 42 | Charles Schwab Investment Management Inc | 20,299 | +940 (+4.86%) | 0.25% | $1 M | Nov 16, 2026 |
| 43 | Teton Advisors, LLC | 20,000 | 0 (0.00%) | 0.24% | $1 M | Nov 12, 2026 |
| 44 | Magnetar Financial LLC | 19,966 | New | 0.24% | $1 M | Nov 13, 2026 |
| 45 | Corsair Capital Management, L.P. | 19,374 | -1,200 (-5.83%) | 0.24% | $1 M | Nov 16, 2026 |
| 46 | Los Angeles Capital Management LLC | 18,863 | -7,545 (-28.57%) | 0.23% | $1 M | Nov 12, 2026 |
| 47 | Voya Investment Management LLC | 17,183 | 0 (0.00%) | 0.21% | $0 M | Nov 10, 2026 |
| 48 | O'shaughnessy Asset Management, LLC | 17,016 | +10,488 (+160.66%) | 0.21% | $0 M | Nov 12, 2026 |
| 49 | Squarepoint Ops LLC | 16,630 | -2,868 (-14.71%) | 0.20% | $0 M | Nov 9, 2026 |
| 50 | American Century Companies Inc | 15,768 | +2,074 (+15.15%) | 0.19% | $0 M | Nov 12, 2026 |
| 51 | Empowered Funds, LLC | 15,539 | New | 0.19% | $0 M | Nov 13, 2026 |
| 52 | Polar Asset Management Partners Inc. | 15,000 | New | 0.18% | $0 M | Nov 16, 2026 |
| 53 | Ritholtz Wealth Management | 14,436 | +8,843 (+158.11%) | 0.18% | $0 M | Nov 5, 2026 |
| 54 | FMR LLC | 14,351 | +12,305 (+601.42%) | 0.18% | $0 M | Nov 10, 2026 |
| 55 | Bridge City Capital, LLC | 13,974 | 0 (0.00%) | 0.17% | $0 M | Oct 29, 2026 |
| 56 | Nuveen, LLC | 13,835 | +677 (+5.15%) | 0.17% | $0 M | Nov 10, 2026 |
| 57 | Victory Capital Management Inc | 13,718 | New | 0.17% | $0 M | Nov 10, 2026 |
| 58 | Wells Fargo & Company/mn | 12,515 | +6,423 (+105.43%) | 0.15% | $0 M | Nov 16, 2026 |
| 59 | Jane Street Group, LLC | 11,972 | New | 0.15% | $0 M | Nov 12, 2026 |
| 60 | Integrated Quantitative Investments LLC | 11,757 | New | 0.14% | $0 M | Nov 13, 2026 |
| 61 | Public Employees Retirement System Of Ohio | 11,744 | New | 0.14% | $0 M | Nov 16, 2026 |
| 62 | Citadel Advisors LLC | 11,657 | -30,388 (-72.27%) | 0.14% | $0 M | Nov 16, 2026 |
| 63 | UBS Group AG | 11,212 | -3,275 (-22.61%) | 0.14% | $0 M | Nov 10, 2026 |
| 64 | Gsa Capital Partners LLP | 10,728 | +1,827 (+20.53%) | 0.13% | $0 M | Nov 16, 2026 |
| 65 | Simplicity Wealth,LLC | 10,640 | New | 0.13% | $0 M | Oct 23, 2026 |
| 66 | HSBC Holdings PLC | 10,623 | -1,163 (-9.87%) | 0.13% | $0 M | Nov 16, 2026 |
| 67 | Sprott Inc. | 10,000 | 0 (0.00%) | 0.12% | $0 M | Nov 9, 2026 |
| 68 | NewEdge Advisors, LLC | 9,995 | +3,491 (+53.67%) | 0.12% | $0 M | Nov 13, 2026 |
| 69 | Martingale Asset Management L P | 9,649 | +605 (+6.69%) | 0.12% | $0 M | Nov 12, 2026 |
| 70 | Verdad Advisers, LP | 9,513 | New | 0.12% | $0 M | Nov 16, 2026 |
| 71 | Barclays PLC | 9,486 | +1,629 (+20.73%) | 0.12% | $0 M | Nov 6, 2026 |
| 72 | HRT Financial LP | 8,960 | New | 0.11% | $0 M | Nov 13, 2026 |
| 73 | Bank Of America Corp /de/ | 8,907 | -28,843 (-76.41%) | 0.11% | $0 M | Nov 16, 2026 |
| 74 | XTX Topco Ltd | 8,595 | +2,119 (+32.72%) | 0.11% | $0 M | Nov 16, 2026 |
| 75 | Rhumbline Advisers | 8,584 | +338 (+4.10%) | 0.10% | $0 M | Nov 10, 2026 |
| 76 | Allspring Global Investments Holdings, LLC | 8,562 | +338 (+4.11%) | 0.10% | $0 M | Nov 4, 2026 |
| 77 | Legacy Wealth Asset Management, LLC | 8,550 | 0 (0.00%) | 0.10% | $0 M | Oct 9, 2026 |
| 78 | Occudo Quantitative Strategies LP | 8,171 | +2,820 (+52.70%) | 0.10% | $0 M | Nov 16, 2026 |
| 79 | Invesco Ltd. | 8,057 | -43,337 (-84.32%) | 0.10% | $0 M | Nov 12, 2026 |
| 80 | Hillsdale Investment Management Inc. | 8,000 | 0 (0.00%) | 0.10% | $0 M | Nov 12, 2026 |
| 81 | Pathstone Holdings, LLC | 7,564 | +3 (+0.04%) | 0.09% | $0 M | Nov 13, 2026 |
| 82 | State Of Wisconsin Investment Board | 7,408 | New | 0.09% | $0 M | Nov 16, 2026 |
| 83 | Deutsche Bank AG\ | 5,800 | -834 (-12.57%) | 0.07% | $0 M | Nov 6, 2026 |
| 84 | Spire Wealth Management | 4,405 | 0 (0.00%) | 0.05% | $0 M | Oct 30, 2026 |
| 85 | MetLife Investment Management, LLC | 4,279 | 0 (0.00%) | 0.05% | $0 M | Nov 16, 2026 |
| 86 | IFP Advisors, Inc | 4,019 | -4 (-0.10%) | 0.05% | $0 M | Oct 16, 2026 |
| 87 | New York State Common Retirement Fund | 3,600 | 0 (0.00%) | 0.04% | $0 M | Nov 17, 2026 |
| 88 | Russell Investments Group, Ltd. | 3,416 | +1,476 (+76.08%) | 0.04% | $0 M | Nov 6, 2026 |
| 89 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 3,220 | +145 (+4.72%) | 0.04% | $0 M | Nov 16, 2026 |
| 90 | Police & Firemen's Retirement System of New Jersey | 2,561 | +1,108 (+76.26%) | 0.03% | $0 M | Nov 9, 2026 |
| 91 | Vanguard Global Advisers, LLC | 2,473 | +31 (+1.27%) | 0.03% | $0 M | Nov 13, 2026 |
| 92 | Legal & General Group Plc | 1,942 | 0 (0.00%) | 0.02% | $0 M | Nov 16, 2026 |
| 93 | State of Wyoming | 1,735 | New | 0.02% | $0 M | Oct 28, 2026 |
| 94 | Royal Bank Of Canada | 1,628 | +722 (+79.69%) | 0.02% | $0 M | Nov 16, 2026 |
| 95 | Financial Management Professionals, Inc. | 1,099 | 0 (0.00%) | 0.01% | $0 M | Oct 23, 2026 |
| 96 | UMB Private Wealth Management, LLC | 1,002 | — | 0.01% | $0 M | Oct 19, 2026 |
| 97 | Citigroup Inc | 976 | -2,776 (-73.99%) | 0.01% | $0 M | Nov 4, 2026 |
| 98 | State of Alaska, Department of Revenue | 785 | 0 (0.00%) | 0.01% | $0 M | Oct 15, 2026 |
| 99 | PNC Financial Services Group, Inc. | 728 | +28 (+4.00%) | 0.01% | $0 M | Nov 6, 2026 |
| 100 | Ameritas Investment Partners, Inc. | 704 | 0 (0.00%) | 0.01% | $0 M | Nov 13, 2026 |
Mutual funds holding Electromed, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 197,135 | $8 M | 2.4% | <0.01% | −20% | Jun 30, 2026 |
| 🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors | 170,748 | $7 M | 2.1% | <0.01% | +7.9% | Jun 30, 2026 |
| 🇺🇸 1290 VT GAMCO Small Company Value PortfolioEquitable Investment Management Group, LLC | 142,000 | $6 M | 1.7% | 0.13% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 79,217 | $3 M | 0.97% | <0.01% | −0.4% | Jun 30, 2026 |
| 🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC | 72,891 | $3 M | 0.89% | <0.01% | +9.4% | Jul 31, 2026 |
| 🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors | 62,716 | $3 M | 0.77% | 0.02% | +13% | Jun 30, 2026 |
| 🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP | 45,979 | $2 M | 0.56% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Small Company Growth PortfolioThe Vanguard Group, Inc. | 38,144 | $2 M | 0.47% | 0.10% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 35,963 | $1 M | 0.44% | <0.01% | −2.6% | May 31, 2026 |
| 🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc. | 34,829 | $1 M | 0.43% | <0.01% | +4.1% | May 31, 2026 |
| 🇺🇸 North Star Micro Cap FundNorth Star Investment Management Corp. | 34,000 | $1 M | 0.42% | 0.70% | new | May 31, 2026 |
| 🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP | 29,778 | $1 M | 0.36% | 0.02% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP | 27,435 | $1 M | 0.34% | <0.01% | +1.6% | Jul 31, 2026 |
| 🇺🇸 The Gabelli Small Cap Growth FundGabelli Funds, LLC | 22,500 | $1 M | 0.28% | 0.05% | −21% | Jun 30, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 22,445 | $1 M | 0.27% | 0.06% | +32% | Jun 30, 2026 |
| 🇺🇸 TETON Westwood Mighty Mites FundTeton Advisors, LLC | 20,000 | $1 M | 0.24% | 0.39% | no change | Jun 30, 2026 |
| 🇺🇸 Strategic Advisers Fidelity U.S. Total Stock FundStrategic Advisers LLC | 21,516 | $1 M | 0.26% | <0.01% | +5.9% | May 31, 2026 |
| 🇺🇸 Acuitas US Microcap FundAcuitas Investments, LLC | 17,376 | $1 M | 0.21% | 0.62% | — | Jun 30, 2026 |
| 🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC | 15,800 | $1 M | 0.19% | 0.45% | −11% | Jun 30, 2026 |
| 🇺🇸 Voya Index Plus Smallcap PortfolioVoya Investments, LLC | 15,661 | $1 M | 0.19% | 0.16% | +1.2% | Jun 30, 2026 |
| 🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc. | 15,756 | $1 M | 0.19% | <0.01% | +7.2% | Jul 31, 2026 |
| 🇺🇸 Strategic Advisers U.S. Total Stock FundStrategic Advisers LLC | 16,055 | $1 M | 0.20% | <0.01% | +6.1% | May 31, 2026 |
| 🇺🇸 U.S. Core Equity 2 PortfolioDimensional Fund Advisors LP | 13,044 | $1 M | 0.16% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 13,987 | $1 M | 0.17% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC | 11,954 | $1 M | 0.15% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 11,056 | $0 M | 0.14% | <0.01% | +151% | Jun 30, 2026 |
| 🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust | 10,908 | $0 M | 0.13% | 0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 10,596 | $0 M | 0.13% | <0.01% | +4.4% | May 31, 2026 |
| 🇺🇸 U.S. Small Cap Growth PortfolioDimensional Fund Advisors LP | 9,743 | $0 M | 0.12% | 0.02% | no change | Jul 31, 2026 |
| 🇺🇸 Avantis U.S. Small Cap Value ETFAmerican Century ETF Trust | 10,245 | $0 M | 0.13% | <0.01% | −65% | May 31, 2026 |
| 🇺🇸 Small Cap Core FundNorthern Trust Investments, Inc. | 8,961 | $0 M | 0.11% | 0.10% | −3.2% | Jun 30, 2026 |
| 🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC | 8,992 | $0 M | 0.11% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 SIMT Small Cap Growth FundSEI Institutional Managed Trust | 8,459 | $0 M | 0.10% | 0.11% | new | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P. | 9,466 | $0 M | 0.12% | 0.04% | +1.3% | May 31, 2026 |
| 🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC | 7,543 | $0 M | 0.09% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Goldman Sachs Small Cap Growth Insights FundGoldman Sachs Asset Management, L.P. | 6,892 | $0 M | 0.08% | 0.09% | +24% | Jul 31, 2026 |
| 🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 6,646 | $0 M | 0.08% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC | 6,248 | $0 M | 0.08% | 0.02% | +21% | Jun 30, 2026 |
| 🇺🇸 Nationwide Bailard Small Cap Value FundNATIONWIDE FUND ADVISORS | 6,434 | $0 M | 0.08% | 0.20% | new | Jul 31, 2026 |
| 🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc. | 6,421 | $0 M | 0.08% | 0.01% | +3.1% | May 31, 2026 |
| 🇺🇸 Allspring Disciplined Small Cap FundAllspring Funds Management, LLC | 5,504 | $0 M | 0.07% | 0.13% | +7.0% | Jun 30, 2026 |
| 🇺🇸 WisdomTree U.S. SmallCap FundWisdomTree Asset Management, Inc. | 5,354 | $0 M | 0.07% | 0.03% | −2.3% | Jun 30, 2026 |
| 🇺🇸 SIMT Small Cap FundSEI Institutional Managed Trust | 5,052 | $0 M | 0.06% | 0.04% | +314% | Jun 30, 2026 |
| 🇺🇸 U.S. Core Equity 1 PortfolioDimensional Fund Advisors LP | 5,226 | $0 M | 0.06% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation | 4,700 | $0 M | 0.06% | <0.01% | −7.8% | Jun 30, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 3,905 | $0 M | 0.05% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC | 3,785 | $0 M | 0.05% | <0.01% | +17% | Jul 31, 2026 |
| 🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc. | 3,464 | $0 M | 0.04% | <0.01% | −5.3% | Jun 30, 2026 |
| 🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc. | 3,594 | $0 M | 0.04% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC | 3,169 | $0 M | 0.04% | <0.01% | +3.6% | Jul 31, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 2,975 | $0 M | 0.04% | <0.01% | −29% | Jun 30, 2026 |
| 🇺🇸 U.S. Vector Equity PortfolioDimensional Fund Advisors LP | 2,971 | $0 M | 0.04% | <0.01% | +37% | Jul 31, 2026 |
| 🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC | 2,600 | $0 M | 0.03% | <0.01% | +37% | Jun 30, 2026 |
| 🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC | 2,583 | $0 M | 0.03% | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc. | 2,500 | $0 M | 0.03% | <0.01% | +19% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company | 2,701 | $0 M | 0.03% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC | 2,491 | $0 M | 0.03% | <0.01% | −1.7% | Jul 31, 2026 |
| 🇺🇸 Invesco Russell 2000 Dynamic Multifactor ETFInvesco Capital Management LLC | 2,570 | $0 M | 0.03% | 0.03% | +171% | May 31, 2026 |
| 🇺🇸 U.S. Sustainability Core 1 PortfolioDimensional Fund Advisors LP | 2,300 | $0 M | 0.03% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 SA U.S. Small Company FundFocus Advisor Solutions, LLC | 2,175 | $0 M | 0.03% | 0.03% | no change | Jun 30, 2026 |
| 🇺🇸 Venerable US Small Cap FundVenerable Investment Advisers, LLC | 1,791 | $0 M | 0.02% | 0.05% | −2.9% | Jun 30, 2026 |
| 🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC | 1,789 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Advisors LLC | 1,700 | $0 M | 0.02% | <0.01% | −5.6% | Jun 30, 2026 |
| 🇺🇸 Avantis U.S. Equity ETFAmerican Century ETF Trust | 1,899 | $0 M | 0.02% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 VIP Disciplined Small Cap PortfolioFidelity Management & Research Company LLC | 1,665 | $0 M | 0.02% | 0.01% | new | Jun 30, 2026 |
| 🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS | 1,605 | $0 M | 0.02% | <0.01% | +29% | Jun 30, 2026 |
| 🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC | 1,531 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC | 1,533 | $0 M | 0.02% | <0.01% | −0.8% | Jun 30, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 1,504 | $0 M | 0.02% | 0.03% | +22% | Jun 30, 2026 |
| 🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC | 1,475 | $0 M | 0.02% | <0.01% | +6.7% | Jun 30, 2026 |
| 🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC | 1,373 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 AST Small-Cap Equity PortfolioAST Investment Services, Inc. | 1,330 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 1,300 | $0 M | 0.02% | <0.01% | +117% | Jun 30, 2026 |
| 🇺🇸 LVIP Dimensional U.S. Core Equity 2 FundLincoln Financial Investments Corporation | 1,109 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Dimensional U.S. Equity Market ETFDimensional Fund Advisors LP | 1,107 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc. | 1,053 | $0 M | 0.01% | <0.01% | +14% | Jun 30, 2026 |
| 🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC | 1,031 | $0 M | 0.01% | <0.01% | +22% | Jun 30, 2026 |
| 🇺🇸 Fidelity Flex Small Cap Index FundFidelity Management & Research Company LLC | 1,047 | $0 M | 0.01% | 0.01% | −0.9% | Jul 31, 2026 |
| 🇺🇸 iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC | 1,031 | $0 M | 0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP | 957 | $0 M | 0.01% | <0.01% | +158% | Jul 31, 2026 |
| 🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc. | 907 | $0 M | 0.01% | <0.01% | +39% | Jun 30, 2026 |
| 🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP | 895 | $0 M | 0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC | 860 | $0 M | 0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Nationwide Fundamental All Cap Equity PortfolioNATIONWIDE FUND ADVISORS | 854 | $0 M | 0.01% | <0.01% | −33% | Jul 31, 2026 |
| 🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC | 794 | $0 M | <0.01% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC | 816 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc. | 792 | $0 M | <0.01% | <0.01% | +1.1% | Jul 31, 2026 |
| 🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC | 784 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management | 704 | $0 M | <0.01% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Dimensional US Vector Equity ETFDimensional Fund Advisors LP | 659 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC | 612 | $0 M | <0.01% | 0.02% | +25% | Jun 30, 2026 |
| 🇺🇸 Avantis U.S. Small Cap Equity FundAmerican Century ETF Trust | 681 | $0 M | <0.01% | 0.02% | no change | May 31, 2026 |
| 🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS | 603 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC | 576 | $0 M | <0.01% | <0.01% | +13% | Jul 31, 2026 |
| 🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC | 548 | $0 M | <0.01% | 0.01% | new | Jun 30, 2026 |
| 🇺🇸 VIP Extended Market Index PortfolioFidelity Management & Research Company LLC | 512 | $0 M | <0.01% | <0.01% | +13% | Jun 30, 2026 |
| 🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC | 490 | $0 M | <0.01% | <0.01% | −14% | Jun 30, 2026 |
| 🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc. | 511 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC | 357 | $0 M | <0.01% | <0.01% | −41% | Jun 30, 2026 |
| 🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC | 318 | $0 M | <0.01% | <0.01% | +8.5% | May 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Electromed, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | James L. CunniffCEO and President, Director | Shares withheld for tax | -2,671 | $27.10 | $72 K | 145,080 | Form 4 |
| filed | Bradley M. NagelChief Financial Officer | Grant or award | +4,900 | — | — | 23,864 | Form 4 |
| filed | Bradley M. NagelChief Financial Officer | Shares withheld for tax | -1,102 | $27.10 | $30 K | 22,762 | Form 4 |
| filed | Bradley M. NagelChief Financial Officer | Shares withheld for tax | -674 | $42.30 | $29 K | 18,964 | Form 4 |
| filed | James L. CunniffCEO and President, Director | Option exercise | +9,700 | $17.25 | $167 K | 157,451 | Form 4 |
| filed | James L. CunniffCEO and President, Director | Sell | -7,003 | $36.25 | $254 K | 150,448 | Form 4 |
| filed | James L. CunniffCEO and President, Director | Sell | -1,671 | $36.80 | $61 K | 148,777 | Form 4 |
| filed | James L. CunniffCEO and President, Director | Sell | -1,026 | $37.77 | $39 K | 147,751 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Electromed, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
| Buybacks, quarter | Fiscal | Spent |
|---|---|---|
| Q3 2026 | Q1 2027 | $4.3M |
| Q2 2026 | Q4 2026 | $0M |
| Q1 2026 | Q3 2026 | $0.2M |
| Q4 2025 | Q2 2026 | $2.8M |
| Q3 2025 | Q1 2026 | $1M |
| Q2 2025 | Q4 2025 | $3.7M |
| Q1 2025 | Q3 2025 | $1.8M |
| Q4 2024 | Q2 2026 | $0M |
| Q3 2024 | Q1 2025 | $4.5M |
| Q2 2024 | Q4 2024 | $0.3M |
| Q2 2023 | Q4 2023 | $0M |
| Q1 2023 | Q3 2023 | $0M |
| Q4 2022 | Q2 2022 | $0M |
| Q3 2022 | Q1 2022 | $0.1M |
| Q2 2022 | Q4 2022 | $0.5M |
| Q1 2022 | Q3 2023 | $0.3M |
Fails to deliver
- : 19 shares at $40.00
- : 36 shares at $42.58
- : 1,053 shares at $42.19
- : 29 shares at $42.04
- : 33 shares at $41.87
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Electromed, Inc. scorecard#
Passes 15 of the 16 checks that could be worked out: strongest in profitability (5 of 5), weakest in growth (5 of 6). Fiscal year 2026; market cap of Aug 1, 2026.
Valuationnot known
- –P/E below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to book below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to sales below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Free cash flow yield above 5%The market cap dates from 2026-08-01, more than 60 days ago.
- –Earnings yield above the 10-year Treasury yieldThe market cap dates from 2026-08-01, more than 60 days ago.
- –The price assumes slower growth than the last three years'The market cap dates from 2026-08-01, more than 60 days ago.
Growth5 of 6
- ✓Revenue grew in the newest year15.3%Revenue up 15.3% in fiscal 2026.
- ✓Revenue up more than 5% a year over three years15.3%15.3% a year over the three years to fiscal 2026.
- ✗Faster growth over three years than its peers' median15.3%15.3% a year against Medical Equipment's median of 24.7% (5 companies).
- ✓Earnings per share grew in the newest year1.30 vs 0.85Diluted EPS 1.30 in fiscal 2026 against 0.85 the year before (report's currency).
- ✓Net income higher than five years earlier$11 M$11 M in fiscal 2026 against $2 M in 2021.
- ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2026.
Profitability5 of 5
- ✓Profitable in the newest year$11 MNet income $11 M in fiscal 2026.
- ✓Profitable in each of the last five years5 of 5Profitable in 5 of the five years to fiscal 2026.
- ✓Operating margin above its peers' median18.8%18.8% against Medical Equipment's median of -38.5% (8 companies).
- ✓Return on equity above 15%23.2%23.2% in fiscal 2026.
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier18.8%18.8% in fiscal 2026 against 8.3% in 2023.
Financial health3 of 3
- ✓Short-term assets cover short-term liabilities4.7×Current ratio 4.69 at the end of fiscal 2026.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2026.
- ✓Altman Z-score outside the distress zone19.87Z-score 19.87 (safe zone) for fiscal 2026.
Shareholder returns2 of 2
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✓Share count up no more than 2% in a year-2.5%Diluted shares down 2.5% in fiscal 2026.
- –Dividends and buybacks above 3% of the market valueThe market cap dates from 2026-08-01, more than 60 days ago.
- ✓Free cash flow covers dividends and buybacks$8 MFree cash flow $8 M against $4 M paid out in fiscal 2026.
Worked out from the statements as filed (sec), the medians of Medical Equipment, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2026#
Worked out from Electromed, Inc.'s statements, beside the median of Medical Equipment.
| Ratio | Trend | 2026 | Median of peers |
|---|---|---|---|
| Operating margin | 18.8% | -38.5% | |
| Net margin | 15.3% | -44.9% | |
| Return on equity | 23.3% | -94.5% | |
| Revenue growth, 3 years a year | 15.4% | 24.7% | |
| Revenue growth | 15.3% | 15.6% | |
| Free cash flow margin | 11.4% | -35.7% |
5of 8on the Piotroski tests of financial strength
- Revenue has grown 13 years in a row.
- The share count fell 2.5% in the year (buybacks).
Electromed, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2026to Jun 30, 2026 | FY 2025to Jun 30, 2025 | FY 2024to Jun 30, 2024 | FY 2023to Jun 30, 2023 | FY 2022to Jun 30, 2022 | FY 2021to Jun 30, 2021 | FY 2020to Jun 30, 2020 | FY 2019to Jun 30, 2019 | FY 2018to Jun 30, 2018 | FY 2017to Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| Revenue | 73,776+15.3%100% | 64,000+17.0%100% | 54,716+13.8%100% | 48,067+15.4%100% | 41,659+16.5%100% | 35,756+10.1%100% | 32,471r32,471+3.7%100% | 31,300+10.6%100% | 28,307r28,698+9.5%100% | 25,861—100% | |
| Cost of revenue | 15,833+12.9%21.5% | 14,029+8.0%21.9% | 12,990+12.5%23.7% | 11,548+13.0%24.0% | 10,217+20.9%24.5% | 8,451+16.2%23.6% | 7,271r7,271−2.4%22.4% | 7,452+14.0%23.8% | 6,534r5,842+23.5%23.1% | 5,293—20.5% | |
| Gross profit | 57,943+16.0%78.5% | 49,971+19.8%78.1% | 41,726+14.3%76.3% | 36,519+16.1%76.0% | 31,442+15.2%75.5% | 27,305+8.4%76.4% | 25,200r25,200+5.7%77.6% | 23,848+9.5%76.2% | 21,773r22,856+5.9%76.9% | 20,568—79.5% | |
| Research and development | 1,314+31.9%1.8% | 996+51.8%1.6% | 656−28.4%1.2% | 916−32.4%1.9% | 1,356−21.3%3.3% | 1,722+64.0%4.8% | 1,050r1,050+80.0%3.2% | 583+132%1.9% | 251−57.9%0.9% | 597—2.3% | |
| Selling, general and administrative | 42,748+8.7%57.9% | 39,315+14.0%61.4% | 34,489+9.2%63.0% | 31,595+16.5%65.7% | 27,114+20.8%65.1% | 22,443+12.5%62.8% | 19,945r19,945−2.4%61.4% | 20,435r20,446+8.6%65.3% | 18,809r19,596+14.7%66.4% | 16,402—63.4% | |
| Operating expenses | 44,062+9.3%59.7% | 40,311+14.7%63.0% | 35,145+8.1%64.2% | 32,511+14.2%67.6% | 28,470+17.8%68.3% | 24,165+20.3%67.6% | 20,082r20,081−4.5%61.8% | 21,018r21,029+10.3%67.2% | 19,060r19,847+12.1%67.3% | 16,999—65.7% | |
| Operating income | 13,881+43.7%18.8% | 9,660+46.8%15.1% | 6,581+64.2%12.0% | 4,008+34.9%8.3% | 2,972−5.4%7.1% | 3,140−38.6%8.8% | 5,118r5,119+80.9%15.8% | 2,830r2,819+4.3%9.0% | 2,712r3,009−24.0%9.6% | 3,569—13.8% | |
| Interest and finance income | — | — | — | — | — | — | — | — | — | 17—0.1% | |
| Net interest income | — | — | 455+483%0.8% | 78+212%0.2% | 25−7.4%0.1% | 27r39−77.7%0.1% | 121r121+33.4%0.4% | 91+356%0.3% | 20—0.1% | −50—−0.2% | |
| Income before tax | 14,360+39.6%19.5% | 10,284+46.2%16.1% | 7,036+72.2%12.9% | 4,086+36.3%8.5% | 2,997−5.4%7.2% | 3,167−39.5%8.9% | 5,239r5,239+79.4%16.1% | 2,920r2,909+6.9%9.3% | 2,732r3,028−22.4%9.7% | 3,519—13.6% | |
| Income tax | 3,059+11.4%4.1% | 2,747+45.7%4.3% | 1,886+105%3.4% | 920+32.9%1.9% | 692−14.0%1.7% | 805−25.3%2.3% | 1,078+14.7%3.3% | 940+4.3%3.0% | 901r1,126−30.2%3.2% | 1,290—5.0% | |
| Net income attributable to shareholders | 11,301+49.9%15.3% | 7,537+46.3%11.8% | 5,150+62.7%9.4% | 3,166+37.4%6.6% | 2,305−2.4%5.5% | 2,362−43.2%6.6% | 4,161r4,161+110%12.8% | 1,980r1,969+8.1%6.3% | 1,831r1,902−17.9%6.5% | 2,229—8.6% | |
| Earnings per share, basic | 1.37+53.9%— | 0.89+48.3%— | 0.60+62.2%— | 0.37+37.0%— | 0.27−3.6%— | 0.28−44.0%— | 0.50+108%— | 0.24+9.1%— | 0.22r0.23−18.5%— | 0.27—— | |
| Earnings per share, diluted | 1.30+52.9%— | 0.85+46.6%— | 0.58+61.1%— | 0.36+38.5%— | 0.26−3.7%— | 0.27−42.6%— | 0.47+104%— | 0.23+9.5%— | 0.21r0.22−19.2%— | 0.26—— | |
| Shares, weighted average (basic) | 8.3−2.2%— | 8.5−1.3%— | 8.6+1.2%— | 8.5−0.1%— | 8.5−1.1%— | 8.6+1.9%— | 8.4+1.2%— | 8.3+1.2%— | 8.2+0.5%— | 8.2—— | |
| Shares, weighted average (diluted) | 8.7−2.5%— | 8.9+0.6%— | 8.9+1.9%— | 8.7−0.8%— | 8.8−1.6%— | 8.9+1.0%— | 8.8+2.3%— | 8.6+0.1%— | 8.6+1.9%— | 8.5—— | |
| Balance sheet | |||||||||||
| Cash and cash equivalents | 20,450+33.8%30.9% | 15,287−4.9%28.4% | 16,080+118%30.8% | 7,372−9.6%16.1% | 8,153−31.4%19.7% | 11,889+13.5%32.0% | 10,479r10,479+34.2%31.5% | 7,808r7,808+4.7%26.6% | 7,456+33.8%27.2% | 5,574—24.2% | |
| Receivables | 29,805+20.9%45.0% | 24,660+5.7%45.8% | 23,333−3.3%44.7% | 24,130+14.6%52.7% | 21,052+23.6%50.9% | 17,032+31.6%45.9% | 12,941r12,941+1.4%38.9% | 12,760+8.0%43.4% | 11,811r11,563+18.7%43.1% | 9,950—43.1% | |
| Inventory | 3,681+11.6%5.6% | 3,299−11.1%6.1% | 3,712−12.1%7.1% | 4,221+32.8%9.2% | 3,178+50.3%7.7% | 2,114−31.5%5.7% | 3,085r3,085+17.7%9.3% | 2,622+5.4%8.9% | 2,487r2,361−2.8%9.1% | 2,559—11.1% | |
| Other current assets | 1,170+198%1.8% | 392+19.1%0.7% | 329−79.1%0.6% | 1,577−15.7%3.4% | 1,870+578%4.5% | 276−21.8%0.7% | 353r353−0.1%1.1% | 353−53.4%1.2% | 757r832+92.6%2.8% | 393—1.7% | |
| Current assets | 57,368+27.3%86.6% | 45,082+2.1%83.8% | 44,173+16.9%84.6% | 37,787+9.4%82.5% | 34,539+8.9%83.5% | 31,704+13.1%85.4% | 28,023r28,023+14.2%84.3% | 24,539+5.4%83.5% | 23,288r22,212+26.0%85.0% | 18,476—80.1% | |
| Property, plant and equipment | 5,214+10.6%7.9% | 4,714−8.7%8.8% | 5,165−8.9%9.9% | 5,672+24.2%12.4% | 4,568+26.7%11.0% | 3,605−4.8%9.7% | 3,788r3,788+5.1%11.4% | 3,605+16.6%12.3% | 3,091−6.4%11.3% | 3,303—14.3% | |
| Right-of-use (leased) assets | 131−33.8%0.2% | 198+128%0.4% | 87—0.2% | — | 120+36.4%0.3% | 88+8.6%0.2% | 81r80+80.0%0.2% | 45—0.2% | — | — | |
| Other intangible assets | 379+2.2%0.6% | 371−43.5%0.7% | 657+8.6%1.3% | 605+1.0%1.3% | 599−9.7%1.4% | 663+10.9%1.8% | 598r598+2.9%1.8% | 581r581−10.5%2.0% | 649r649−10.0%2.4% | 721r721—3.1% | |
| Total assets | 66,267+23.2%100% | 53,802+3.0%100% | 52,234+14.0%100% | 45,806+10.7%100% | 41,364+11.5%100% | 37,109+11.6%100% | 33,245r33,245+13.1%100% | 29,399r29,354+7.3%100% | 27,392r26,638+18.8%100% | 23,061—100% | |
| Accounts payable | 2,643−0.9%4.0% | 2,667+164%5.0% | 1,010−26.4%1.9% | 1,372+8.8%3.0% | 1,261+84.1%3.0% | 685+23.2%1.8% | 556r556−5.2%1.7% | 587−27.6%2.0% | 811+22.2%3.0% | 663—2.9% | |
| Debt due within a year | — | — | — | — | — | 33−54.2%0.1% | 72r72+137%0.2% | 300.0%0.1% | 30r1,101−40.2%0.1% | 51—0.2% | |
| Current liabilities | 12,222+16.8%18.4% | 10,468+36.4%19.5% | 7,677−4.7%14.7% | 8,053+12.6%17.6% | 7,150+54.1%17.3% | 4,639+55.4%12.5% | 2,986r2,986−18.2%9.0% | 3,651r3,620−24.0%12.4% | 4,803r4,743+65.9%17.5% | 2,896—12.6% | |
| Long-term debt | — | — | — | — | — | — | — | — | — | 1,097—4.8% | |
| Total liabilities | 12,288+16.0%18.5% | 10,593+37.8%19.7% | 7,689−5.5%14.7% | 8,139+13.2%17.8% | 7,191+53.2%17.4% | 4,693+56.7%12.6% | 2,995r2,995−18.3%9.0% | 3,665−22.7%12.5% | 4,743+18.8%17.3% | 3,993—17.3% | |
| Retained earnings | 28,564+34.8%43.1% | 21,185−10.5%39.4% | 23,668+25.9%45.3% | 18,793+19.1%41.0% | 15,780+5.7%38.1% | 14,922+9.0%40.2% | 13,684r13,684+43.7%41.2% | 9,522r9,5220.0%32.4% | 9,522r6,859+92.1%34.8% | 4,957—21.5% | |
| Shareholders' equity | 53,979+24.9%81.5% | 43,209−3.0%80.3% | 44,545+18.3%85.3% | 37,667+10.2%82.2% | 34,173+5.4%82.6% | 32,416+7.2%87.4% | 30,250r30,249+17.5%91.0% | 25,735r25,734+14.0%87.5% | 22,578r21,895+13.8%82.4% | 19,833r19,068—86.0% | |
| Total liabilities and equity | 66,267+23.2%100% | 53,802+3.0%100% | 52,234+14.0%100% | 45,806+10.7%100% | 41,364+11.5%100% | 37,109+11.6%100% | 33,245r33,245+13.1%100% | 29,399r29,354+7.3%100% | 27,392r26,638+18.8%100% | 23,061—100% | |
| Shares outstanding | 8.4+0.2%— | 8.3−3.3%— | 8.6+1.0%— | 8.6r8.6+0.9%— | 8.5−0.7%— | 8.5−0.4%— | 8.6+1.9%— | 8.4+1.4%— | 8.3+0.7%— | 8.2—— | |
| Cash-flow statement | |||||||||||
| Share-based compensation | 2,722−11.0%3.7% | 3,059+80.8%4.8% | 1,692+139%3.1% | 708−27.5%1.5% | 976−4.7%2.3% | 1,024+13.5%2.9% | 902r902−2.4%2.8% | 924+7.1%3.0% | 863+79.9%3.0% | 479—1.9% | |
| Cash from operating activities | 9,665−15.2%13.1% | 11,393+25.7%17.8% | 9,067+590%16.6% | 1,315—2.7% | −686−122%−1.6% | 3,077−26.7%8.6% | 4,196r4,196+62.0%12.9% | 2,590+6.0%8.3% | 2,442+105%8.6% | 1,191—4.6% | |
| Capital expenditure | −1,252—−1.7% | −262—−0.4% | −287—−0.5% | −1,648—−3.4% | −1,425—−3.4% | −287—−0.8% | −844r−844—−2.6% | −1,331—−4.3% | −526—−1.9% | −619—−2.4% | |
| Intangible assets bought | −48—−0.1% | −44—−0.1% | −108—−0.2% | −68—−0.1% | −100—−0.2% | −161—−0.5% | −133r−133—−0.4% | −58—−0.2% | −46—−0.2% | −68—−0.3% | |
| Cash from investing activities | −1,300—−1.8% | −306—−0.5% | −395—−0.7% | −1,716—−3.6% | −1,525—−3.7% | −448—−1.3% | −977r−977—−3.0% | −1,387—−4.4% | −572—−2.0% | −687—−2.7% | |
| Shares bought back | −3,918—−5.3% | −10,000—−15.6% | −275—−0.5% | −153—−0.3% | −1,448—−3.5% | −1,124—−3.1% | — | — | — | — | |
| Cash from financing activities | −3,202—−4.3% | −11,880−33100%−18.6% | 36—0.1% | −380—−0.8% | −1,525—−3.7% | −1,219—−3.4% | −548r−548—−1.7% | −851−7367%−2.7% | 12—0.0% | −54—−0.2% | |
| Change in cash | 5,163—7.0% | −793−109%−1.2% | 8,708—15.9% | −781—−1.6% | −3,736−365%−9.0% | 1,410−47.2%3.9% | 2,671r2,671+659%8.2% | 352—1.1% | — | — | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q1 FY2027to Sep 30, 2026 | Q4 FY2026to Jun 30, 2026 | Q3 FY2026to Mar 31, 2026 | Q2 FY2026to Dec 31, 2025 | Q1 FY2026to Sep 30, 2025 | Q4 FY2025to Jun 30, 2025 | Q3 FY2025to Mar 31, 2025 | Q2 FY2025to Dec 31, 2024 | Q1 FY2025to Sep 30, 2024 | Q4 FY2024to Jun 30, 2024 | Q3 FY2024to Mar 31, 2024 | Q2 FY2024to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 75,571+14.1%100% | 18,682+10.6%100% | 19,417*+11.6%100% | 18,575+18.4%100% | 18,897+16.3%100% | 16,887+15.1%100% | 17,393*+17.3%100% | 15,684+13.1%100% | 16,255+18.7%100% | 14,668—100% | 14,832*—100% | 13,871—100% | 13,689—100% | |
| Cost of revenue | 15,888+9.3%21.0% | 3,745+1.5%20.0% | 4,133*+9.7%21.3% | 3,932+13.8%21.2% | 4,078+12.4%21.6% | 3,690+16.1%21.9% | 3,769*+6.7%21.7% | 3,455−1.0%22.0% | 3,628+15.4%22.3% | 3,177—21.7% | 3,531*—23.8% | 3,489—25.2% | 3,144—23.0% | |
| Gross profit | 59,683+15.5%79.0% | 14,937+13.2%80.0% | 15,284*+12.2%78.7% | 14,643+19.7%78.8% | 14,819+17.4%78.4% | 13,197+14.8%78.1% | 13,624*+20.6%78.3% | 12,229+17.8%78.0% | 12,627+19.7%77.7% | 11,491—78.3% | 11,301*—76.2% | 10,382—74.8% | 10,545—77.0% | |
| Research and development | 1,350+26.1%1.8% | 277+14.9%1.5% | 328*+8.6%1.7% | 361+30.3%1.9% | 384+53.0%2.0% | 241+45.2%1.4% | 302*+71.6%1.7% | 277+65.9%1.8% | 251+135%1.5% | 166—1.1% | 176*—1.2% | 167—1.2% | 107—0.8% | |
| Selling, general and administrative | 43,633+8.5%57.7% | 11,171+8.6%59.8% | 11,131*+8.3%57.3% | 10,516+7.2%56.6% | 10,815+10.0%57.2% | 10,286+9.6%60.9% | 10,282*+17.0%59.1% | 9,812+17.2%62.6% | 9,834+20.3%60.5% | 9,387—64.0% | 8,790*—59.3% | 8,374—60.4% | 8,175—59.7% | |
| Operating expenses | 44,983+9.0%59.5% | 11,448+8.7%61.3% | 11,459*+8.3%59.0% | 10,877+7.8%58.6% | 11,199+11.0%59.3% | 10,527+10.2%62.3% | 10,584*+18.0%60.9% | 10,089+18.1%64.3% | 10,085+21.8%62.0% | 9,553—65.1% | 8,966*—60.5% | 8,541—61.6% | 8,282—60.5% | |
| Operating income | 14,700+41.5%19.5% | 3,489+30.7%18.7% | 3,825*+25.8%19.7% | 3,766+76.0%20.3% | 3,620+42.4%19.2% | 2,670+37.8%15.8% | 3,040*+30.2%17.5% | 2,140+16.2%13.6% | 2,542+12.3%15.6% | 1,938—13.2% | 2,335*—15.7% | 1,841—13.3% | 2,263—16.5% | |
| Net interest income | — | — | — | — | — | — | — | — | 152+58.3%0.9% | 195—1.3% | 162*—1.1% | 120—0.9% | 96—0.7% | |
| Income before tax | 15,193+38.7%20.1% | 3,637+29.7%19.5% | 3,961*+24.8%20.4% | 3,866+69.4%20.8% | 3,729+38.4%19.7% | 2,804+31.5%16.6% | 3,175*+27.2%18.3% | 2,282+16.4%14.5% | 2,694+14.2%16.6% | 2,133—14.5% | 2,497*—16.8% | 1,961—14.1% | 2,359—17.2% | |
| Income tax | 3,267+18.5%4.3% | 876+31.1%4.7% | 560*−42.3%2.9% | 863+121%4.6% | 968+33.3%5.1% | 668+1.4%4.0% | 971*+45.1%5.6% | 391−16.5%2.5% | 726+6.0%4.5% | 659—4.5% | 669*—4.5% | 468—3.4% | 685—5.0% | |
| Net income attributable to shareholders | 11,926+45.5%15.8% | 2,761+29.3%14.8% | 3,401*+54.3%17.5% | 3,003+58.8%16.2% | 2,761+40.3%14.6% | 2,136+44.9%12.6% | 2,204*+20.6%12.7% | 1,891+26.7%12.1% | 1,968+17.6%12.1% | 1,474—10.0% | 1,828*—12.3% | 1,493—10.8% | 1,674—12.2% | |
| Earnings per share, basic | — | 0.33+26.9%— | — | 0.37+68.2%— | 0.33+43.5%— | 0.26+52.9%— | — | 0.22+29.4%— | 0.23+15.0%— | 0.17—— | — | 0.17—— | 0.20—— | |
| Earnings per share, diluted | — | 0.32+28.0%— | — | 0.35+66.7%— | 0.32+45.5%— | 0.25+56.3%— | — | 0.21+23.5%— | 0.22+15.8%— | 0.16—— | — | 0.17—— | 0.19—— | |
| Shares, weighted average (basic) | 8.3−0.2%— | 8.3−0.2%— | — | 8.2−3.3%— | 8.3−1.8%— | 8.3−2.8%— | — | 8.5−0.8%— | 8.4−1.4%— | 8.6—— | — | 8.6—— | 8.5—— | |
| Shares, weighted average (diluted) | 8.8+0.9%— | 8.8+0.9%— | — | 8.6−3.6%— | 8.7−2.9%— | 8.7−3.3%— | — | 9.0+0.8%— | 9.0+1.7%— | 9.0—— | — | 8.9—— | 8.8—— | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 15,875—26.0% | 15,875+12.5%26.0% | 20,450+33.8%30.9% | 16,985+11.5%28.6% | 13,791−15.1%25.1% | 14,113+1.8%26.3% | 15,287−4.9%28.4% | 15,237+30.1%29.0% | 16,235+55.6%31.1% | 13,864—28.3% | 16,080—30.8% | 11,712—24.0% | 10,434—22.2% | |
| Receivables | 30,267—49.5% | 30,267+22.3%49.5% | 29,805+20.9%45.0% | 28,251+20.5%47.5% | 26,260+15.3%47.8% | 24,756+10.7%46.2% | 24,660+5.7%45.8% | 23,442−1.9%44.7% | 22,775−0.9%43.6% | 22,366—45.7% | 23,333—44.7% | 23,907—48.9% | 22,988—48.9% | |
| Inventory | 3,811—6.2% | 3,811+1.1%6.2% | 3,681+11.6%5.6% | 3,295+11.0%5.5% | 3,458+12.2%6.3% | 3,771+9.8%7.0% | 3,299−11.1%6.1% | 2,968−29.0%5.7% | 3,081−35.3%5.9% | 3,434—7.0% | 3,712—7.1% | 4,178—8.5% | 4,760—10.1% | |
| Other current assets | 810—1.3% | 810+49.2%1.3% | 1,170+198%1.8% | 596+21.1%1.0% | 906+54.3%1.6% | 543−8.3%1.0% | 392+19.1%0.7% | 492−16.9%0.9% | 587+15.3%1.1% | 592—1.2% | 329—0.6% | 592—1.2% | 509—1.1% | |
| Current assets | 52,194—85.4% | 52,194+17.1%85.4% | 57,368+27.3%86.6% | 50,228+13.7%84.5% | 45,567+3.1%83.0% | 44,559+8.7%83.1% | 45,082+2.1%83.8% | 44,195+7.0%84.3% | 44,189+12.5%84.5% | 41,010—83.8% | 44,173—84.6% | 41,322—84.5% | 39,265—83.6% | |
| Property, plant and equipment | 5,168—8.5% | 5,168+3.8%8.5% | 5,214+10.6%7.9% | 5,209+8.2%8.8% | 5,218+0.0%9.5% | 4,978−0.5%9.3% | 4,714−8.7%8.8% | 4,813−8.9%9.2% | 5,216−3.0%10.0% | 5,003—10.2% | 5,165—9.9% | 5,283—10.8% | 5,377—11.4% | |
| Right-of-use (leased) assets | 115—0.2% | 115−36.1%0.2% | 131−33.8%0.2% | 146—0.2% | 161—0.3% | 180—0.3% | 198+128%0.4% | — | — | — | 87—0.2% | — | — | |
| Other intangible assets | 379—0.6% | 379−2.6%0.6% | 379+2.2%0.6% | 354−39.8%0.6% | 387−36.5%0.7% | 389−41.1%0.7% | 371−43.5%0.7% | 588−9.3%1.1% | 609−1.1%1.2% | 660—1.3% | 657—1.3% | 648—1.3% | 616—1.3% | |
| Total assets | 61,094—100% | 61,094+14.0%100% | 66,267+23.2%100% | 59,474+13.4%100% | 54,910+5.0%100% | 53,614+9.6%100% | 53,802+3.0%100% | 52,451+7.3%100% | 52,274+11.3%100% | 48,915—100% | 52,234—100% | 48,901—100% | 46,964—100% | |
| Accounts payable | 2,347—3.8% | 2,347−25.2%3.8% | 2,643−0.9%4.0% | 2,595+38.1%4.4% | 2,320+54.1%4.2% | 3,138+75.9%5.9% | 2,667+164%5.0% | 1,879+137%3.6% | 1,506+44.7%2.9% | 1,784—3.6% | 1,010—1.9% | 792—1.6% | 1,041—2.2% | |
| Current liabilities | 7,261—11.9% | 7,261−17.1%11.9% | 12,222+16.8%18.4% | 10,226+20.2%17.2% | 9,375+8.2%17.1% | 8,759+18.1%16.3% | 10,468+36.4%19.5% | 8,511+34.5%16.2% | 8,667+31.9%16.6% | 7,419—15.2% | 7,677—14.7% | 6,326—12.9% | 6,573—14.0% | |
| Total liabilities | 8,621—14.1% | 8,621−2.8%14.1% | 12,288+16.0%18.5% | 10,307+21.1%17.3% | 9,471+9.2%17.2% | 8,869+19.4%16.5% | 10,593+37.8%19.7% | 8,511+33.9%16.2% | 8,671+30.9%16.6% | 7,427—15.2% | 7,689—14.7% | 6,357—13.0% | 6,622—14.1% | |
| Retained earnings | 26,970—44.1% | 26,970+20.9%44.1% | 28,564+34.8%43.1% | 25,135+11.4%42.3% | 22,283−1.3%40.6% | 22,308+8.4%41.6% | 21,185−10.5%39.4% | 22,555+2.0%43.0% | 22,577+9.5%43.2% | 20,587—42.1% | 23,668—45.3% | 22,115—45.2% | 20,622—43.9% | |
| Shareholders' equity | 52,473—85.9% | 52,473+17.3%85.9% | 53,979+24.9%81.5% | 49,167+11.9%82.7% | 45,439+4.2%82.8% | 44,745+7.9%83.5% | 43,209−3.0%80.3% | 43,940+3.3%83.8% | 43,603+8.1%83.4% | 41,488—84.8% | 44,545—85.3% | 42,544—87.0% | 40,342—85.9% | |
| Total liabilities and equity | 61,094—100% | 61,094+14.0%100% | 66,267+23.2%100% | 59,474+13.4%100% | 54,910+5.0%100% | 53,614+9.6%100% | 53,802+3.0%100% | 52,451+7.3%100% | 52,274+11.3%100% | 48,915—100% | 52,234—100% | 48,901—100% | 46,964—100% | |
| Shares outstanding | 8.2—— | 8.2−1.4%— | 8.4+0.2%— | 8.3−2.7%— | 8.3−3.2%— | 8.4−1.2%— | 8.3−3.3%— | 8.5−1.7%— | 8.6−0.5%— | 8.5—— | 8.6—— | 8.7—— | 8.6—— | |
| Cash-flow statement | ||||||||||||||
| Share-based compensation | 2,699−4.3%3.6% | 435−5.0%2.3% | 762*+17.2%3.9% | 846*+11.8%4.6% | 656*−31.3%3.5% | 458−34.3%2.7% | 650*+47.1%3.7% | 757*+64.9%4.8% | 955*+127%5.9% | 697—4.8% | 442*—3.0% | 459*—3.3% | 420*—3.1% | |
| Cash from operating activities | 9,869+6.7%13.1% | 373+121%2.0% | 2,994*−22.4%15.4% | 3,476*+67.6%18.7% | 3,026*−4.0%16.0% | 169−92.7%1.0% | 3,859*−14.0%22.2% | 2,074*+53.5%13.2% | 3,151*−9.2%19.4% | 2,309—15.7% | 4,489*—30.3% | 1,351*—9.7% | 3,471*—25.4% | |
| Capital expenditure | −1,165—−1.5% | −165—−0.9% | −219*—−1.1% | −147*—−0.8% | −634*—−3.4% | −252—−1.5% | −145*—−0.8% | — | −233*—−1.4% | −37—−0.3% | −22*—−0.1% | −85*—−0.6% | −71*—−0.5% | |
| Intangible assets bought | −70—−0.1% | −37—−0.2% | −4.0*—−0.0% | −7.0*—−0.0% | −22*—−0.1% | −15—−0.1% | −12*—−0.1% | −7.0*—−0.0% | −4.0*—−0.0% | −21—−0.1% | −24*—−0.2% | −44*—−0.3% | −16*—−0.1% | |
| Cash from investing activities | −1,235—−1.6% | −202—−1.1% | −223*—−1.1% | −154*−205%−0.8% | −656*—−3.5% | −267—−1.6% | −157*—−0.9% | 146*—0.9% | −237*—−1.5% | −58—−0.4% | −46*—−0.3% | −129*—−0.9% | −87*—−0.6% | |
| Shares bought back | −7,243—−9.6% | −4,328—−23.2% | 0*—0.0% | −152*—−0.8% | −2,763*—−14.6% | −1,003—−5.9% | −3,669*—−21.1% | −1,795*—−11.4% | 0*—0.0% | −4,536r−4,558—−30.9% | −275*—−1.9% | — | — | |
| Cash from financing activities | −6,872—−9.1% | −4,746—−25.4% | 694*—3.6% | −128*—−0.7% | −2,692*—−14.2% | −1,076—−6.4% | −3,652*—−21.0% | −3,218*−5846%−20.5% | −543*−2188%−3.3% | −4,467—−30.5% | −75*—−0.5% | 56*—0.4% | 26*—0.2% | |
| Change in cash | 1,762+608%2.3% | −4,575—−24.5% | 3,465*+6830%17.8% | 3,194*—17.2% | −322*−114%−1.7% | −1,174—−7.0% | 50*−98.9%0.3% | −998*−178%−6.4% | 2,371*−30.5%14.6% | −2,216—−15.1% | 4,368*—29.4% | 1,278*—9.2% | 3,410*—24.9% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What Electromed, Inc. sells: revenue by product line, fiscal 2026#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2025. Lines can overlap (a total and its parts), so they are not added up.
Countries and regions
- Non-US(total)$0 M0.6%+68%
Source: SEC annual report (XBRL data) · as of Jun 30, 2026
Executive pay at Electromed, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2026James L. Cunniff | $1.8 M | $4.3 M | $836 K | $395 |
| 2025James L. Cunniff | $1.5 M | $4.9 M | $757 K | $205 |
| 2024James L. Cunniff | $3.0 M | $4.4 M | $553 K | $140 |
Source: SEC proxy statement (Form DEF 14A) · as of Jun 30, 2026
Events at Electromed, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Directors and officers 1 · Material agreement 2 · New debt 2 · Bylaws or fiscal year changed 1 · Shareholder vote 3 · Results announced 13
| Filed | What happened | Filing |
|---|---|---|
| Results announced | 8-K | |
| Directors and officersResults announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Material agreementNew debt | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Bylaws or fiscal year changedShareholder vote | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Material agreementNew debt | 8-K | |
| Shareholder vote | 8-K | |
| Results announced | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 10, 2026
How Electromed, Inc. compares in Medical Equipment
- Market cap$341 M · higher than 71% of 8
- Revenue$74 M · higher than 44% of 19
- Net margin15.8% · highest of 17
- Revenue growth15.3% · higher than 58% of 13
- Price / sales4.5× · lower than 33% of 7
- Price / book6.3× · lower than 17% of 7
- FCF yield2.5% · higher than 83% of 7
- 🇺🇸 Viemed Healthcare, Inc.$367 M
- 🇨🇦 Profound Medical Corp.$240 M
- 🇺🇸 Avita Medical, Inc.$525 M
- 🇺🇸 Streamex Corp.$52 M
- 🇺🇸 TELA Bio, Inc.$52 M
- 🇺🇸 IRIDEX Corporation$12 M
Peer comparison · Medical Equipment
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Electromed, Inc.🇺🇸 | $341 M | 28.6× | 15.8% | +15.3% |
| Avita Medical, Inc.🇺🇸 | $525 M | — | -42.6% | +11.5% |
| Viemed Healthcare, Inc.🇺🇸 | $367 M | 23.5× | 5.0% | +20.5% |
| Profound Medical Corp.🇨🇦 | $240 M | — | -137.4% | +50.8% |
| Streamex Corp.🇺🇸 | $52 M | — | — | +100.0% |
| TELA Bio, Inc.🇺🇸 | $52 M | — | -53.6% | +15.8% |
| IRIDEX Corporation🇺🇸 | $12 M | — | -6.9% | +8.2% |
| Beyond Air, Inc.🇺🇸 | $4 M | — | -407.6% | +107.6% |
| Varian Medical Systems🇺🇸 | $16.3 B | — | 8.5% | -1.8% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Viemed Healthcare, Inc.$367 M
- Profound Medical Corp.$240 M
- Avita Medical, Inc.$525 M
- Streamex Corp.$52 M
- TELA Bio, Inc.$52 M
- IRIDEX Corporation$12 M
Sources and freshness
- Market cap:
- Aug 1, 2026
- Annual results:
- For year ending June-2026
- Balance sheet:
- As of June-2026
- Employees:
- As of June 30, 2026
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Electromed, Inc.? Verify and update this profile — free
Show Electromed, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.